cancer immunotherapy based mutation-specific cd4+t cells patient epithelial cancer 
limited evidence exists humans mount mutation-specific t cell response epithelial cancers used whole-exomic-sequencing-based approach demonstrate tumor-infiltrating lymphocytes til patient metastatic cholangiocarcinoma contained cd4+ t helper th1 cells recognizing mutation erbb2 interacting protein erbb2ip expressed cancer adoptive transfer til containing % mutation-specific polyfunctional th1 cells patient achieved decrease target lesions prolonged stabilization disease upon disease progression patient retreated >% pure population mutation-reactive th1 cells experienced tumor regression results provide evidence cd4+ t cell response mutated antigen can harnessed mediate regression metastatic epithelial cancer 
